Sensex surges 330 points, Nifty above 10,500 at close; Sun Pharma, Dr. Reddy’s top gainers
Major gainers that supported Thursday’s recovery were Sun Pharma, Dr.Reddy’s, Infosys, Axis Bank, TCS , HDFC and Wipro. Sun Pharma closed 6.32% higher at Rs 583.40.business Updated: Feb 08, 2018 16:01 IST
Indian equity benchmark BSE Sensex recovered more than 300 points on Thursday on buying in realty, IT, capital goods and banking stocks after the RBI maintained status quo in its monetary policy review on Wednesday.
The 30-share index rose by 0.97% or 330.45 points to close at 34,413.16. All but one of the sectoral indices led by realty, IT, healthcare and banking closed in the green. BSE Oil & Gas was down by 0.25%, while BSE Realty was higher by 2.51% at close.
The gauge had lost 2,200.54 points in the previous seven sessions.
The broader NSE Nifty 50 closed at 10,576.85, up 0.96% or 100.15 points, after it briefly surpassed the 10,600 mark in the late morning session.
Major gainers that supported the recovery were Sun Pharma, Dr.Reddy’s, Infosys, Axis Bank, TCS , HDFC and Wipro. Sun Pharma closed 6.32% higher at Rs 583.40.
Brokers said buying by domestic institutional investors (DIIs) and a mixed trend at other Asian bourses improved the market sentiment.
DIIs had bought shares worth Rs 461.19 crore, while foreign funds sold shares to the tune of Rs 1,022.50 crore yesterday.
In the Asian region, Hong Kong’s Hang Seng was up 0.48% while Japan’s Nikkei higher 0.26% in early trade today. Shanghai Composite Index, however, shed 0.81%.
The U.S. Dow Jones Industrial Average index ended marginally lower by 0.08% on Wednesday.